Arkolith/Insider Trading/IMMX/Form 4

Hsu Jason

DirectorImmix Biopharma, Inc. (IMMX) · full profile →Form 4 · filed Jul 31, 2024
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 24, 2024Buy(P)6K$2.15$13K822K
Jul 18, 2024Buy(P)3K$2.07$7K816K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-029810) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML